New study tests cheaper vs. fancier care for high blood pressure in HIV patients

NCT ID NCT05609513

Completed Disease control Sponsor: Infectious Diseases Research Collaboration, Uganda Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jul 24, 2026 · Updated 3 times

Summary

This study looked at two strategies to help Ugandans living with HIV and high blood pressure get better care. One strategy provided free blood pressure medicines and equipment, while the other added extra staff and support. Over 87,000 patients took part. The goal was to see which approach works best to control blood pressure and is worth the cost.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: amlodipine, valsartan, hydrochlorothiazide
What this could lead to: If successful, this could show a cost-effective way to manage high blood pressure in people with HIV in Uganda, potentially saving lives.
What could go wrong: This is an implementation study, not a test of new drugs. Results may not apply to other countries or populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

AIDS HIV infectious disease hypertensive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV/AIDS HYPERTENSION

Contacts and locations

Locations

Butabika

Kampala, Uganda
Bweyogerere

Wakiso, Uganda
Entebbe RRH

Wakiso, Uganda
Kakiri

Wakiso, Uganda
Kawala

Kampala, Uganda
Kawanda

Wakiso, Uganda
Kisenyi

Kampala, Uganda
Kitebi

Kampala, Uganda
Komamboga

Kampala, Uganda
Mengo Hospital

Kampala, Uganda
Naguru

Kampala, Uganda
Nakawuka HCIII

Wakiso, Uganda
Nsambya

Kampala, Uganda
Nsangi HCIII

Wakiso, Uganda
Nurture Africa

Wakiso, Uganda
Saidina

Wakiso, Uganda

More trials for these conditions

Other studies related to the condition(s) this trial covers.